» Articles » PMID: 16687413

Diet-induced Obesity Alters AMP Kinase Activity in Hypothalamus and Skeletal Muscle

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2006 May 12
PMID 16687413
Citations 121
Authors
Affiliations
Soon will be listed here.
Abstract

AMP-activated protein kinase (AMPK) is a key regulator of cellular energy balance and of the effects of leptin on food intake and fatty acid oxidation. Obesity is usually associated with resistance to the effects of leptin on food intake and body weight. To determine whether diet-induced obesity (DIO) impairs the AMPK response to leptin in muscle and/or hypothalamus, we fed FVB mice a high fat (55%) diet for 10-12 weeks. Leptin acutely decreased food intake by approximately 30% in chow-fed mice. DIO mice tended to eat less, and leptin had no effect on food intake. Leptin decreased respiratory exchange ratio in chow-fed mice indicating increased fatty acid oxidation. Respiratory exchange ratio was low basally in high fat-fed mice, and leptin had no further effect. Leptin (3 mg/kg intraperitoneally) increased alpha2-AMPK activity 2-fold in muscle in chow-fed mice but not in DIO mice. Leptin decreased acetyl-CoA carboxylase activity 40% in muscle from chow-fed mice. In muscle from DIO mice, acetyl-CoA carboxylase activity was basally low, and leptin had no further effect. In paraventricular, arcuate, and medial hypothalamus of chow-fed mice, leptin inhibited alpha2-AMPK activity but not in DIO mice. In addition, leptin increased STAT3 phosphorylation 2-fold in arcuate of chow-fed mice, but this effect was attenuated because of elevated basal STAT3 phosphorylation in DIO mice. Thus, DIO in FVB mice alters alpha2-AMPK in muscle and hypothalamus and STAT3 in hypothalamus and impairs further effects of leptin on these signaling pathways. Defective responses of AMPK to leptin may contribute to resistance to leptin action on food intake and energy expenditure in obese states.

Citing Articles

The role and function of lncRNA in ageing-associated liver diseases.

Zarandi P, Ghiasi M, Heiat M RNA Biol. 2024; 22(1):1-8.

PMID: 39697114 PMC: 11660375. DOI: 10.1080/15476286.2024.2440678.


Anorexigenic and anti-inflammatory signaling pathways of semaglutide via the microbiota-gut--brain axis in obese mice.

da Silva R, de Paiva I, Mendonca I, de Souza J, Lucena-Silva N, Peixoto C Inflammopharmacology. 2024; 33(2):845-864.

PMID: 39586940 DOI: 10.1007/s10787-024-01603-y.


Inhibits Lipogenesis Activity in the Hepatocytes of High-Fat High-Fructose-Induced Rats by Increasing the Levels of SIRT1 and AMPK.

Anggreini P, Kuncoro H, Sumiwi S, Levita J J Exp Pharmacol. 2024; 16:351-364.

PMID: 39403317 PMC: 11471891. DOI: 10.2147/JEP.S473763.


The Mechanism of Leptin Resistance in Obesity and Therapeutic Perspective.

Engin A Adv Exp Med Biol. 2024; 1460:463-487.

PMID: 39287862 DOI: 10.1007/978-3-031-63657-8_16.


Protein Kinases in Obesity, and the Kinase-Targeted Therapy.

Engin A Adv Exp Med Biol. 2024; 1460:199-229.

PMID: 39287853 DOI: 10.1007/978-3-031-63657-8_7.